HOME >> MEDICINE >> NEWS
NIAID researchers show how promising TB drug works

Scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have determined how a promising drug candidate attacks the bacterium that causes tuberculosis (TB). Published online this week in Proceedings of the National Academy of Sciences, the finding may help scientists optimize the drug candidate, PA-824, which targets Mycobacterium tuberculosis (M. tb).

"PA-824, now in early stage clinical trials, holds promise for shortening the TB treatment regimen, which is currently cumbersome and lengthy," says NIAID Director Anthony S. Fauci, M.D. "This new finding will allow a streamlined approach for making improved versions of the drug."

"Previously, we were flying blind in trying to optimize PA-824 in a rational way because we didn't know which M. tb protein was the target of PA-824's action," says NIAID scientist Clifton Barry, III, Ph.D., who headed the research team.

In preclinical testing, PA-824 showed evidence of being effective against both actively dividing and slow-growing M. tb, giving rise to optimism that the compound may be useful in treating both active and latent TB. (For information about the first clinical trial of PA-824, see June 14, 2005, NIAID press release: http://www3.niaid.nih.gov/news/newsreleases/2005/tb_pa_824.htm.)

PA-824 must be chemically activated in the bacterium before it exerts its anti-tubercular effect, notes Dr. Barry. Earlier research had sketched out the first few steps in this process, but Dr. Barry and his colleagues wanted to pinpoint the precise protein that binds PA-824 and transforms it into a lethal molecule for TB.

The scientists approached the problem indirectly by searching for M. tb mutants that resisted the killing power of PA-824. The team confirmed previous research suggesting that resistance usually occurs when M. tb lacks components
'"/>

Contact: Anne A. Oplinger
aoplinger@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
26-Dec-2005


Page: 1 2 3

Related medicine news :

1. NIAID releases MDR/XDR Tuberculosis research agenda
2. NIAID DNA vaccine for H5N1 avian influenza enters human trial
3. NIAID media availability: Examining genetic variability of malaria parasite offers insight
4. NIAID awards $4 million to develop anti-radiation treatments
5. Partnership between NIAID and Sequella yields promising new TB drug for clinical testing
6. NIAID announces leadership for newly restructured HIV/AIDS clinical trials networks
7. NIAID study finds higher dose of flu vaccine improves immune response in the elderly
8. NIAID media availability: New study describes key protein from highly pathogenic H5N1 avian flu virus and how it might mutate
9. NIAID media availability: Understanding influenza infection
10. NIAID awards $47 million to develop medical countermeasures against radiological, nuclear threats
11. NIAID launches first Phase II trial of a global HIV/AIDS vaccine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/14/2019)... ... January 15, 2019 , ... Early bird pricing for Medical Device Risk Management: ... just plain hard, complicated, conflicted, confusing. And it is getting even more complicated , ... intended as “major”, the new standard adds new definitions, changes the clause numbering, introduces ...
(Date:1/14/2019)... ... January 14, 2019 , ... The Centers for Disease Control ... (Varicella Zoster Immune Globulin [Human]) for post-exposure prophylaxis of varicella in patients at ... notes that VARIZIG is commercially available from a broad network of specialty distributors ...
(Date:1/14/2019)... SCOTCH PLAINS, N.J. (PRWEB) , ... January 14, 2019 , ... NJ Top Docs Proudly Presents All Reviewed & Approved Living Well Providers of 2019. ... Iverson - Paramus , Dr. Edward Izrailov - Maplewood , Dr. Joanna Jodar ... Princeton , Dr. Robert Lenahan - Point Pleasant , Dr. Robert J. Reinhardt ...
(Date:1/14/2019)... ... January 14, 2019 , ... Specialty Technical Publishers ... International Audit Protocol Consortium (IAPC) EHS audit protocol for Great Britain . ... scope of their EHS regulatory obligations and rapidly collect, share, archive, and export ...
(Date:1/13/2019)... ... January 12, 2019 , ... On December 13th, The ... University hosted a continuing education (CEU) event entitled, Can You Hear Me Now? ... create a series of talks to help develop and cultivate the relationship between ...
Breaking Medicine News(10 mins):
(Date:1/21/2019)... MATEO, Calif. (PRWEB) , ... January 21, 2019 , ... ... California, California Casualty is providing a $7,500 School Lounge Makeover® to make ... classes in a temporary building 25 miles away in Chico, Paradise Intermediate School (PINT) ...
(Date:1/20/2019)... ... January 19, 2019 , ... California firefighter Trent Knuckles is the latest ... He won one of three prize packages that included a check for $2,250 to ... tactical gear that included a carry bag, backpack, RAID Glasses, flashlight, hats and more. ...
(Date:1/15/2019)... (PRWEB) , ... January 15, 2019 , ... ... twelve new course locations for the 2019 Wound Certification Prep Course (WCPC), the ... to possess increased specialized knowledge in wound management, WCPC will be expanding its ...
Breaking Medicine Technology:
Cached News: